Paniti Sukumvanich MD
General Gynecology, Gynecologic Oncology
Associate Professor, Ob/Gyn & Reproductive Science, University of Pittsburgh School of Medicine
Join to View Full Profile
300 Halket StSte 0610Pittsburgh, PA 15213
Phone+1 412-641-4200
Dr. Sukumvanich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Gynecologic Oncology, 2001 - 2004
UPMC Medical EducationResidency, Obstetrics and Gynecology, 1997 - 2001
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1997
Certifications & Licensure
PA State Medical License 1998 - 2026
NY State Medical License 2001 - 2007
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer Start of enrollment: 2008 Dec 01
- Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- The Role of Adjuvant Chemotherapy in Endometrial Cancer Following Preoperative Neoadjuvant Chemoradiation Therapy.Margaret R Flanigan, Michelle Ertel, John A Vargo, Li Wang, Michelle M Boisen
American Journal of Clinical Oncology. 2025-04-23 - All-cause mortality and neighborhood social vulnerability among women with ovarian cancer.Austin Hicks, Lauren Borho, Esther Elishaev, Jessica Berger, Michelle Boisen
Gynecologic Oncology. 2025-04-01 - Adjuvant Therapy in Early Uterine Serous Carcinoma.Alison A Garrett, Taylor H Orellana, T Rinda Soong, Taylor A Rives, Sarah E Taylor
American Journal of Epidemiology. 2025-01-16
Journal Articles
- Survival Advantage Associated with Multimodal Therapy in Women with Node‐Positive (Stage‐IIIC) Uterine Papillary Serous Carcinoma: A National Cancer Database StudyJ F Lin, K Muniz, P Gehrig, R P Edwards, A B Olawaiye, S Beriwal, P Sukumvanich, J L Kelley, BJOG: An International Journal of Obstetrics & Gynaecology
Press Mentions
The Toughest 9 Months: Pregnant with CancerMarch 2nd, 2016
The Power of Shared Purpose: Transforming Gynecologic Cancer CareMarch 26th, 2024
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
